Amtrust (AFSI) (ANTH) (OII) (RDEN) (SKH) (SUNH) Downgraded

Amtrust Financial Services, Inc. (NASDAQ: AFSI), Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), Oceaneering International (NYSE: OII), Elizabeth Arden, Inc. (NASDAQ: RDEN), Skilled Healthcare Group, Inc. (NYSE: SKH) and Sun Healthcare Group, Inc. (NASDAQ: SUNH) downgraded by analysts.

Amtrust Financial Services, Inc. (AFSI) was downgraded by Keefe, Bruyette & Woods, Inc from an “Outperform” rating to a “Market Perform” rating.

Anthera Pharmaceuticals, Inc. (ANTH) was downgraded by Wedbush from an “Outperform” rating to a “Neutral” rating. They have a price target of $7.00 on the company, down from $9.00.

Oceaneering International (OII) was downgraded by Credit Suisse (NYSE:CS) from an “Outperform” rating to a “Neutral” rating. They have a price target of $48.00 on the company.

Elizabeth Arden, Inc. (RDEN) was downgraded by SunTrust (NYSE:STI) from a “Buy” rating to a “Neutral” rating.

Skilled Healthcare Group, Inc. (SKH) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $6.75 on the company, down from $14.00.

Sun Healthcare Group, Inc. (SUNH) was downgraded by Morgan Keegan from an “Outperform” rating to a “Market Perform” rating. They have a price target of $4.00 on the company, down from $11.00.

Origin Agritech (SEED) (SKH) (SUNH) (TSYS) Downgraded

Origin Agritech Ltd (NASDAQ: SEED), Skilled Healthcare Group, Inc. (NYSE: SKH), Sun Healthcare Group, Inc. (NASDAQ: SUNH) and TeleCommunication Systems, Inc. (NASDAQ: TSYS) downgraded by analysts.

Origin Agritech Ltd (SEED) was downgraded by Chardan Capital Markets to a “neutral” rating.

Skilled Healthcare Group, Inc. (SKH) was downgraded by JMP Securities from an “outperform” rating to a “market perform” rating.

Sun Healthcare Group, Inc. (SUNH) was downgraded by JMP Securities from an “outperform” rating to a “market perform” rating.

TeleCommunication Systems, Inc. (TSYS) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) to a “neutral” rating. They have a price target of $6.50 on the company.

Ratings on (OPEN) (ORIT) (RJET) (SFUN) (SKH) Upgraded by Analysts

Analysts upgraded ratings on OpenTable Inc (NASDAQ: OPEN), Oritani Financial Corp. (NASDAQ: ORIT), Republic Airways Holdings Inc. (NASDAQ: RJET), SouFun Holdings (NASDAQ: SFUN) and Skilled Healthcare Group, Inc. (NYSE: SKH) today.

Bank of America (NYSE:BAC) upgraded OpenTable Inc (OPEN) from a “neutral” rating to a “buy” rating.

Sandler O’Neill upgraded Oritani Financial Corp. (ORIT) to a “buy” rating.

Evercore Partners upgraded Republic Airways Holdings Inc. (RJET) from an “underweight” rating to an “equal weight” rating.

Goldman Sachs (NYSE:GS) upgraded SouFun Holdings (SFUN) from a “neutral” rating to a “buy” rating.

DA Davidson upgraded Skilled Healthcare Group, Inc. (SKH) from a “neutral” rating to a “buy” rating. They have a price target of $16.50 on the company, up from $15.00.

Skilled Healthcare (NYSE:SKH) EPS Estimate Boosted on Favorable Medicare Environment

Skilled Healthcare Group (NYSE:SKH) had their EPS estimates raised by Barclays, based on an extremely favorable Medicare environment.

Barclays says, "In short, the market had been anticipating a strong number from SKH given that Kindred (NYSE:KND)'s guidance was much better than expected in mid-December and had implied a very favorable Medicare reimbursement environment for 2011. That said, we believe guidance was well ahead of market expectations. With this news, we are increasing our 2010 EPS estimate to $1.03 (from $0.95), increasing 2011 to $1.26 (from $0.93) and introducing our preliminary estimate for 2012 of $1.33."

Barclays maintains an "Equalweight" rating on Skilled Healthcare Group, which closed Friday at $10.70, gaining $0.04, or 0.38 percent. Barclays raised their price target on Skilled from $6 to $12.

Skilled Healthcare (NYSE:SKH) Guidance Should Improve for 2011

Barclays (NYSE:BCS) says Skilled Healthcare Group (NYSE:SKH) guidance should be revealed as better-than-expected for 2011.

"We believe it is increasingly likely that SKH will provide better-than-expected guidance for 2011, either in advance of its presentation at an investor conference in early January or in conjunction with the company's 4Q10 results. We highlight that the stock has traded higher this week on the news that HCP was going to buy ManorCare's real estate (we do believe SKH should get some recognition for the inherent value of their real estate, noting that they own 74%) and we believe the press release issued last night by Kindred Healthcare (NYSE: KND) will be another positive catalyst for the shares of SKH, given that KND's guidance implies that nursing homes which are focused on higher acuity patients will receive a substantial benefit from RUG-IV," said Barclays.

Barclays maintains an "Equalweight" on Skilled Healthcare Group, which closed Thursday at $8.47, up $0.55, or 6.94 percent. Barclays has a price target on them of $6.